research

Rolapitant improves quality of life of patients receiving highly or moderately emetogenic chemotherapy

Authors
    Publication date
    28 November 2016
    Publisher
    Springer
    Doi

      Abstract

      Abstract is not available.

        Similar works

        Full text

        thumbnail-image

        Available Versions

        Springer - Publisher Connector

        redirect
        Last time updated on 30/04/2017